Seguir
Roufosse Florence
Roufosse Florence
Médecine Interne, Hôpital Erasme,Université Libre de Bruxelles
Dirección de correo verificada de erasme.ulb.ac.be
Título
Citado por
Citado por
Año
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
P Valent, AD Klion, HP Horny, F Roufosse, J Gotlib, PF Weller, ...
Journal of Allergy and Clinical Immunology 130 (3), 607-612. e9, 2012
8092012
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
ME Rothenberg, AD Klion, FE Roufosse, JE Kahn, PF Weller, HU Simon, ...
New England Journal of Medicine 358 (12), 1215-1228, 2008
6612008
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy
PU Ogbogu, BS Bochner, JH Butterfield, GJ Gleich, J Huss-Marp, JE Kahn, ...
Journal of Allergy and Clinical Immunology 124 (6), 1319-1325. e3, 2009
6562009
Refining the definition of hypereosinophilic syndrome
HU Simon, ME Rothenberg, BS Bochner, PF Weller, AJ Wardlaw, ...
Journal of allergy and clinical immunology 126 (1), 45-49, 2010
3712010
Practical approach to the patient with hypereosinophilia
F Roufosse, PF Weller
Journal of Allergy and Clinical Immunology 126 (1), 39-44, 2010
3542010
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
P Vandenberghe, I Wlodarska, L Michaux, P Zachée, M Boogaerts, ...
Leukemia 18 (4), 734-742, 2004
2452004
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes
FE Roufosse, JE Kahn, GJ Gleich, LB Schwartz, AD Singh, ...
Journal of allergy and clinical immunology 131 (2), 461-467. e5, 2013
2292013
Hypereosinophilic syndromes
FE Roufosse, M Goldman, E Cogan
Orphanet journal of rare diseases 2, 1-12, 2007
2232007
Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome
F Roufosse, L Schandené, C Sibille, K Willard‐Gallo, B Kennes, A Efira, ...
British journal of haematology 109 (3), 540-548, 2000
2142000
Recent advances in pathogenesis and management of hypereosinophilic syndromes
F Roufosse, E Cogan, M Goldman
Allergy 59 (7), 673-689, 2004
2002004
Lymphocytic variant hypereosinophilic syndromes
F Roufosse, E Cogan, M Goldman
Immunology and allergy clinics of North America 27 (3), 389-413, 2007
1812007
The hypereosinophilic syndrome revisited
F Roufosse, E Cogan, M Goldman
Annual Review of medicine 54 (1), 169-184, 2003
1812003
Novel targeted therapies for eosinophilic disorders
ME Wechsler, PC Fulkerson, BS Bochner, GM Gauvreau, GJ Gleich, ...
Journal of allergy and clinical immunology 130 (3), 563-571, 2012
1802012
Targeting the interleukin-5 pathway for treatment of eosinophilic conditions other than asthma
F Roufosse
frontiers in Medicine 5, 49, 2018
1752018
Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field
P Valent, GJ Gleich, A Reiter, F Roufosse, PF Weller, A Hellmann, ...
Expert review of hematology 5 (2), 157-176, 2012
1752012
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial
F Roufosse, JE Kahn, ME Rothenberg, AJ Wardlaw, AD Klion, SY Kirby, ...
Journal of Allergy and Clinical Immunology 146 (6), 1397-1405, 2020
1322020
Sustained response to mepolizumab in refractory Churg-Strauss syndrome
JE Kahn, C Grandpeix-Guyodo, I Marroun, E Catherinot, F Mellot, ...
Journal of allergy and clinical immunology 125 (1), 267-270, 2010
1302010
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome
F Roufosse, A De Lavareille, L Schandené, E Cogan, A Georgelas, ...
Journal of allergy and clinical immunology 126 (4), 828-835. e3, 2010
1152010
High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome
A De Lavareille, F Roufosse, P Schmid-Grendelmeier, AS Roumier, ...
Journal of allergy and clinical immunology 110 (3), 476-479, 2002
992002
A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis
M Vanthuyne, D Blockmans, R Westhovens, F Roufosse, E Cogan, ...
Clinical and experimental rheumatology 25 (2), 287, 2007
892007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20